Results 31 to 40 of about 51,398 (196)
Targeted treatment with somatostatin analogues: widening horizons of clinical practice
Alʹmanah Kliničeskoj Mediciny, 2022 Targeted treatment with somatostatin analogues (SA) in acromegaly and neuroendocrine neoplasms may have some benefits compared to curative treatments, because these agents decrease excessive hormone secretion and exert a tumor-suppressive effect ...
Vyacheslav S. Pronin +3 more
doaj +1 more source
Case Reports in Oncology, 2014 Pancreatic neuroendocrine tumors (NETs), including poorly differentiated carcinomas (NECs), are rarely encountered. The majority of these tumors do not secrete excess hormones, but functioning NETs produce large amounts of vasoactive peptides and may ...
Frank Van Fraeyenhove +7 more
doaj +1 more source
Expressions of Cushing’s syndrome in multiple endocrine neoplasia type 1
Frontiers in Endocrinology, 2023 Cushing’s syndrome (CS) resulting from endogenous hypercortisolism can be sporadic or can occur in the context of familial disease because of pituitary or extra-pituitary neuroendocrine tumors.
William F. Simonds
doaj +1 more source
The malignant carcinoid syndrome.A case report with biochemical studies
Cancer, 1956 Sherwood B. Fein, Kenneth P. Knudtson
openaire +4 more sources
Síndrome carcinóide: relato de caso Carcinoid syndrome: case report
Anais Brasileiros de Dermatologia, 2008 Os tumores carcinóides são raros, com incidência aproximada de um a dois casos por 100.000 habitantes. Estima-se que a síndrome carcinóide - que se caracteriza por flushing, diarréia, dor abdominal e, em menor freqüência, pelagra, broncoespasmo e doença ...
Ane Beatriz Mautari Niwa +1 more
doaj +1 more source
Endocrine Oncology, 2023 Ectopic adrenocorticotrophic hormone (ACTH) secretion (EAS) is a rare cause of ACTH-dependent Cushing’s syndrome (CS), most often caused by a thoracic neuroendocrine tumor (NET).
Stéphanie Larose +3 more
doaj +1 more source
Frontiers in Endocrinology, 2017 Ectopic adrenocorticotropic hormone (ACTH) syndrome is a challenging diagnosis only responsible for approximately 10% of Cushing syndrome cases. It has been associated with a variety of benign and malignant tumors including a carcinoid tumor accompanied ...
Kyoung Jin Kim +5 more
doaj +1 more source
THE MALIGNANT CARCINOID SYNDROME ASSOCIATED WITH A METASTASIZING BRONCHIAL ADENOMA
The Journal of Thoracic and Cardiovascular Surgery, 1962 Robert J. McConaghie
openaire +3 more sources
Year in Review 2018 by the Brazilian Gastrointestinal Tumors Group: Neuroendocrine Tumors
Brazilian Journal of Oncology, 2018 Neuroendocrine tumors (NET) constitute a heterogeneous group of neoplasms with variable prognoses and clinical presentations. Therefore their therapeutic management is challenging, involving a real multidisciplinary approach composed of medical ...
Duilio R. Rocha +2 more
doaj +1 more source
Contrast-Enhanced Computed Tomography Imaging Features of Primary Hepatic Neuroendocrine Carcinoma in a 4-Year-Old French Bulldog. [PDF]
Vet Med SciA 4‐year‐old female‐spayed French bulldog presented with symptoms of anorexia, lethargy, 22 and vomiting. Abdominal ultrasonography revealed multiple coalescing hyperechoic nodules 23 in the liver. Single‐phase contrast‐enhanced computed tomography (CT) scan showed 24 heterogeneous liver lobes with hyperattenuating parenchyma and multiple ...
Sim H +5 more
europepmc +2 more sources